ArticleCurrent medical imaging2025
Machine Learning based Radiomics from Multi-parametric Magnetic Resonance Imaging for Predicting Lymph Node Metastasis in Cervical Cancer.
Article in Current medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- SPP1 promotes lymph node metastasis and malignant progression of head and neck squamous cell carcinoma by activating FAK-AKT signaling pathway.World journal of surgical oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionConstruct and compare multiple machine learning models to predict lymph node (LN) metastasis in cervical cancer, utilizing radiomic features extracted from preoperative multi-parametric magnetic resonance imaging (MRI).
methodsThis study retrospectively enrolled 407 patients with cervical cancer who were randomly divided into a training cohort (n=284) and a validation cohort (n=123). A total of 4065 radiomic features were extracted from the tumor regions of interest on contrast-enhanced T1-weighted imaging, T2-weighted imaging, and diffusion-weighted imaging for each patient. The Mann-Whitney U test, Spearman correlation analysis, and selection operator Cox regression analysis were employed for radiomic feature selection. The relationship between MRI radiomic features and LN status was analyzed using five machine-learning algorithms. Model performance was evaluated by measuring the area under the receiver-operating characteristic curve (AUC) and accuracy (ACC). Moreover, Kaplan-Meier analysis was used to validate the prognostic value of selected clinical and radiomic characteristics.
resultsLN metastasis was pathologically detected in 24.3% (99/407) of patients. Following a three-step feature selection, 18 radiomic features were employed for model construction. The XGBoost model exhibited superior performance compared to other models, achieving an AUC, accuracy, sensitivity, specificity, and F1 score of 0.9268, 0.8969, 0.7419, 0.9891, and 0.8364, respectively, on the validation set. Additionally, Kaplan-Meier curves indicated a significant correlation between radiomic scores and progression-free survival in cervical cancer patients (p < 0.05). DISCUSSION: Among the machine learning models, XGBoost demonstrated the best predictive ability for LN metastasis and showed prognostic value through its radiomic score, highlighting its clinical potential.
conclusionMachine learning-based multi-parametric MRI radiomic analysis demonstrated promising performance in the preoperative prediction of LN metastasis and clinical prognosis in cervical cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.